KIMBRA JOYCE: Open Payments
NPI 1033525589 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,425 in 204 payments from 22 companies in 2025. Trend: 2023 $3,388 · 2024 $3,687 · 2025 $3,425
Food & beverage: $3,425
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $498 |
| ABBVIE INC. | 27 | $449 |
| Novo Nordisk Inc | 23 | $375 |
| Lilly USA, LLC | 20 | $282 |
| PFIZER INC. | 19 | $260 |
| Astellas Pharma US Inc | 9 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 22 | $176 |
| Merck Sharp & Dohme LLC | 9 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $156 |
| Exact Sciences Corporation | 7 | $136 |
Products named: AIRSUPRA, JARDIANCE, Veozah, VRAYLAR, Ozempic, Kerendia, NURTEC ODT, REXULTI.
Industry payments across OH — which companies pay providers there.
